# Increasing the Scalability of Toxin-Intein Orthogonal Combinations

Rocio López-Igual, Pedro Dorado-Morales, Didier Mazel

► To cite this version:

Rocio López-Igual, Pedro Dorado-Morales, Didier Mazel. Increasing the Scalability of Toxin-Intein Orthogonal Combinations. ACS Synthetic Biology, 2023, 12 (2), pp.618-623. 10.1021/acssyn-bio.2c00477. pasteur-04955125

HAL Id: pasteur-04955125

https://pasteur.hal.science/pasteur-04955125v1

Submitted on 18 Feb 2025

HAL is a multi-disciplinary open access
archive for the deposit and dissemination of sci-
entific research documents, whether they are pub-
lished or not. The documents may come from
teaching and research institutions in France or
abroad, or from public or private research centers.

L'archive ouverte pluridisciplinaire HAL, est
destinée au dépôt et à la diffusion de documents
scientifiques de niveau recherche, publiés ou non,
émanant des établissements d'enseignement et de
recherche français ou étrangers, des laboratoires
publics ou privés.

<figure><img src="image_1.png" /></figure>

Distributed under a Creative Commons Attribution 4.0 International License
# Increasing the Scalability of Toxin-Intein Orthogonal Combinations

Rocío López-Igual,\* Pedro Dorado-Morales, and Didier Mazel

<figure><img src="image_2.png" /></figure>

Cite This: ACS Synth. Biol. 2023, 12, 618–623

<figure><img src="image_3.png" /></figure>

Read Online

ACCESS

<figure><img src="image_4.png" /></figure>

Metrics & More

<figure><img src="image_5.png" /></figure>

Article Recommendations

<figure><img src="image_6.png" /></figure>

Supporting Information

<figure><img src="image_7.png" /></figure>

**ABSTRACT:** Inteins are proteins embedded into host proteins from which they are excised in an autocatalytic reaction. Specifically, split inteins are separated into two independent fragments that reconstitute the host protein during the catalytic process. We recently developed a novel strategy for the specific killing of pathogenic and antibiotic resistant bacteria based on toxin–intein combinations. Bacterial type II toxin–antitoxin systems are protein modules in which the toxin can provoke cell death whereas the antitoxin inhibits toxin activity. Although our previous system was based on a split intein (iDnaE) and the CcdB toxin, we demonstrated that iDnaE is able to reconstitute four different toxins. To expand the applicability of our system by widening the repertoire of toxin–intein combinations for complex set-ups, we introduced a second intein, iDnaX, which was artificially split. We demonstrate that iDnaX is able to reconstitute the four toxins, and we manage to reduce its scar size to facilitate their use. In addition, we prove the orthogonality of both inteins (iDnaE and iDnaX) through a toxin reconstitution assay, thus opening the possibility for complex set-ups based on these toxin–intein modules. This could be used to develop specific antimicrobial and other biotechnological applications.

**KEYWORDS:** toxin–antitoxin systems, inteins, protein splicing, bacterial killing, microbial synthetic biology

Many synthetic biology developments aim at reprogramming bacteria to design and construct sophisticated new biological circuits, which already have multiple applications in biotechnology and medicine.¹⁻⁴ However, if complexity of synthetic biological systems is ever increasing, it is accompanied by a parallel increase in potential parasite interactions with endogenous systems.⁵ The capacity of the components of a system to work independently, i.e., without interaction with other components, the orthogonality, is thus an essential prerequisite to construct robust synthetic biological systems.

One of the most urgent challenges in drug discovery is to find novel chemical or biological molecules that may act as antibacterial agents. Bacterial toxin–antitoxin (TA) systems are based on a two component module consisting of a toxic protein that inhibits cell growth or kills the bacteria, and an antitoxin molecule that modulates toxin activity.⁶ A few but

important applications for TA systems as tools for biotechnology and molecular biology have been proposed.⁷⁻¹⁰ Type II TA systems involve, by definition, a toxic protein whose activity is inhibited by a proteic antitoxin. Toxins are small proteins with an efficient antibacterial activity for which spontaneous resistance is inexistent or extremely rare, because, although a toxin-resistant mutant has been generated,⁷ this was obtained after a laborious protocol. Consequently, toxins from the type II TA systems are potential drug targets¹¹ and also

Received: September 3, 2022

Published: January 27, 2023

<figure><img src="image_8.png" /></figure>
<figure><img src="image_9.png" /><figcaption>**Figure 1.** Intein-toxin activity assay *in vivo*. Growth on LB media with the antibiotics needed to maintain the two plasmids, in two different conditions: repressive (1% glucose) or inducible (1 mM IPTG and 0.2% arabinose). Each plate has three different plasmid combinations: “N” with N-terminal fusion plasmid, “C” with the C-terminal fusion plasmid and “N + C” with both plasmids. For “N” and “C”, the bacteria also carries the empty partner plasmidic vector to allow bacteria to grow on the same media.</figcaption></figure>

candidates for the development of antimicrobials, as we previously showed.¹²

Inteins are dynamic protein sequences embedded within unrelated host proteins, from which they are excised in a maturation process called protein splicing. During the splicing process, the intein catalyzes its own excision, ligating the host protein flanks with a peptide bond and allowing the reconstitution of the mature protein, the extein (Figure S1). Inteins are considered to be disturbing extein activity, which is functionally compromised before protein splicing. Most of the inteins are located within one gene and catalyze their own splicing in *cis*, but naturally split inteins exist, in which the splicing domains are found in different genes (Figure S1). Inteins have been identified in the three domains of life, but they are particularly abundant in bacteria and archaea, where they generally interrupt genes that are essential for DNA replication and metabolism. Although recent advances in intein research may position them as mobile genetic elements and, as such, they might play a dynamic role in the evolution of species, their origin and possible role is still unclear.¹³

To further expand the applications of our antibacterial system,¹² new toxin-intein units are needed. Among these potential applications is that of adapting it to other bacterial species, allowing us to potentially treat clinical cases caused by multiple bacteria. In addition, one of the practical solutions to reduce the development of resistance, a problem associated with antibacterial treatments, is the use of multiple killing systems. However, the multiplicity of combinations in a system

based on toxin-intein units will only be scalable if these parts are orthogonal. In our setup, orthogonality should be operative for both parts: toxins and inteins. Apart from a recent work that showed a large set of split inteins and their orthogonality,¹⁴ there are very few studies addressing trans-splicing between inteins from different families.¹⁵ Here, we describe the construction of an artificially split intein named iDnaX.¹⁶ Using the constructions we previously developed with the wild type iDnaE split intein,¹² we demonstrate that one can fully substitute the iDnaE split intein to reassemble the four toxins we previously tested. We further demonstrate that the parts of our four toxins are orthogonal—with both split inteins—i.e., they only produce functional toxin when partnered with their cognate half. Finally, we show that the four parts from our two inteins are orthogonal as well, as they only produce extein fusion when partnering with their cognate half.

Our results represent an advance in the availability of tools such as split toxins and inteins, and provide new parts for the development of smart antibiotics that could act simultaneously.

## ■ RESULTS AND DISCUSSION

We had selected the type II toxins based on the availability of their crystal structure, to avoid splitting the protein in a constrained domain, as intein excision leaves a scar of additional amino acids. The toxins we selected were CcdB from Vibrio fischeri, and RelE4, HigB2, and ParE2 from Vibrio cholerae. In our previous study,¹² we split toxins into two
<figure><img src="image_10.png" /><figcaption>**Figure 2.** Orthogonality of toxins halves (a) and split inteins (b). *E. coli* spots on LB antibiotics and either 1% glucose or 1 mM IPTG and 0.2% arabinose, incubated at 37 °C overnight. Each spot corresponds to a bacteria harboring two plasmids: one carrying the N-terminal intein–toxin fusion listed in the first column, and the other plasmid with the C-terminal fusion as listed above the spots. (a) Orthogonality of toxin halves. In all tested fusions the intein is iDnaE, and the fused toxin is indicated for each combination of plasmids. (b) Orthogonality of intein halves. In all fusions the toxin is CcdB, and the fused intein half is indicated for each combination of plasmid. Spots are made from 10-fold serial dilutions.</figcaption></figure>

fragments and fused them to the naturally split intein, DnaE from the cyanobacterium *Nostoc punctiforme*, named iDnaE (Figure S2). Here, we designed a new system with an intein that we artificially disrupted, iDnaX from the cyanobacterium *Synechocystis* sp. This intein had already been shown to function when split,<sup>16</sup> avoiding the sequence for the homing endonuclease, but it was made in such a way that the scar left was of 6 specific amino acids (IDECHT). The first three (IDE) come from the N-terminal part and the last (CHT) are encoded into the C-terminal region being the natural sequence of one amino acid different (CHM). Here, we select the same split sequence based in the previous study<sup>16</sup> and we reduce the remaining sequence to 3 amino acids (CHM) (Figure S3), keeping its natural sequence and demonstrating that the intein kept its functionality. Each toxin-split_intein (hereafter named S_intein) fusion part was cloned in a different compatible plasmid, as described for iDnaE.<sup>12</sup> The reconstitution of functional toxins using iDnaX S_intein was found to be effective only when the two plasmids (N and C) were hosted together in the same cell (Figure 1). However, although the artificial iDnaX S_intein was able to perform protein splicing and reconstitution of all toxins tested, we observed a little background growth (Figure 1), which will be addressed below.

Taking into account that the toxins used in this study belong to different families, we did not expect to get a toxic product after reconstitution by mixing their halves. However, it is possible that these artificial products could have collateral negative effects for the cell. In order to determine the orthogonality of our toxin system, we transformed *E. coli* MG1655 with all 25 pairwise combinations of toxin–intein fusion plasmids N and C for the same intein, iDnaE, and tested the growth in media containing either glucose, repressor, or IPTG and arabinose, the inducers of the expression for both parts (Figure 2a). Bacteria died only when the original toxin was reconstituted, but not in any other combination where the halves from different toxins were mixed. This orthogonality was also checked within the same toxin, RelE4, split in two different locations, where we also observed functional reconstitution only with the two cognate partners, i.e., split at the same location. We then can affirm that our toxin modules are orthogonal.

We also tested the orthogonality of our two split inteins. *Synechocystis* contains several inteins including iDnaX, and an iDnaE orthologous. iDnaE orthologous split inteins have been shown to have trans-splicing activity,<sup>17,18</sup> and their sequences are highly conserved (Figure S4). Inside *Synechocystis*, as
with RelE4 and the mutants with residual sequences, the experiment was performed as described previously.²¹

**Plasmid Construction.** Primers used in this work are listed in Table S1. Plasmid and strains used or constructed in this work are listed in Table S2. Plasmids for iDnaE intein fusions were constructed as described previously.¹² To generate the N and C plasmids for DnaX-toxin fusions, the N- and C-terminal toxin regions were amplified with the primers F-toxin-*EcoRI*/R-toxin-DnaX and F-toxin-DnaX/R-toxin-XbaI, respectively. N- and C-terminal DnaX intein regions were amplified with the primers F-DnaX-toxin/R-DnaX-XbaI and F-DnaX-*EcoRI*/R-DnaX-toxin, respectively. We used chromosomal DNA from *V. cholerae* as a template for toxin genes *parE2*, *higB2*, and *relE4*, and *V. fischeri* DNA for *ccdB*. Intein amplification was done with chromosomal DNA from the cyanobacterium *Synechocystis* sp. PCC 6803. PCR products of N- and C-terminal regions were fused by Gibson assembly.²² Each toxin–intein fusion was then digested with *EcoRI/XbaI* (Thermo Fisher) and then cloned in *EcoRI/XbaI* digested pBAD43²³ and pSU38²⁴ plasmids, respectively.

For constructions of RelE4 toxin with the residual sequences CFN or CHM from iDnaE or iDnaX, respectively, we used the construction RelE4-pBAD43 that was previously done.²¹ Then, the additional sequences were added by performing PCR using this plasmid as a template and the following primers: F-RelE4-CFN-1/R-RelE4-CFN-1 or F-RelE4-CHM-1/R-RelE4-CHM-1, to add the CFN or CHM in the split site 1 from RelE4, respectively; and F-RelE4-CFN-2/R-RelE4-CFN-2 or F-RelE4-CHM-2/R-RelE4-CHM-2, to add CFN or CHM in the split site 2, respectively. Gibson assembly was performed in order to ligate the PCR of the whole plasmid and then this reaction was used to transform *V. cholerae* (as in ref 25), because this strain contained the antitoxin in their genome. Sanger sequencing was performed in order to check constructions. We then transformed *E. coli* MG1655 strain to do the assay (as explained before). Before carrying out the assay, we sequenced the plasmids again in order to be sure that we did not select mutations in the toxin.

## ASSOCIATED CONTENT

### Supporting Information

The Supporting Information is available free of charge at https://pubs.acs.org/doi/10.1021/acssynbio.2c00477.

Figure S1: Schematic illustration of protein splicing; Figure S2: Protein sequences for iDnaE intein from *Nostoc punctiforme*; Figure S3: Protein sequences for iDnaX intein from *Synechocystis* sp.; Figure S4: Amino acid sequence conservation by using Blast; Figure S5: Toxicity test of RelE4 toxin and its derivatives carrying the intein residual sequences; Figure S6: Growth test of *E. coli* MG1655 strain along time course after induction; Figure S7: Toxin–intein activity assay in different genetic backgrounds; Table S1: Bacterial strains and plasmids used in this study; Table S2: Primers used in this study; Table S3: Information summarizing the cell death along time in time course experiments (n = 3) (Figure S6) (PDF)

## AUTHOR INFORMATION

### Corresponding Author

Rocío López-Igual — Institut Pasteur, Université de Paris, Unité Plasticité du Génome Bactérien, et CNRS, UMR3525,

F-75015 Paris, France; Instituto de Bioquímica Vegetal y Fotosíntesis, CSIC and Universidad de Sevilla, E-41092 Seville, Spain; orcid.org/0000-0002-2369-1583; Email: mligual@us.es

### Authors

Pedro Dorado-Morales — Institut Pasteur, Université de Paris, Unité Plasticité du Génome Bactérien, et CNRS, UMR3525, F-75015 Paris, France; orcid.org/0000-0001-5760-1999

Didier Mazel — Institut Pasteur, Université de Paris, Unité Plasticité du Génome Bactérien, et CNRS, UMR3525, F-75015 Paris, France; orcid.org/0000-0001-6482-6002

Complete contact information is available at: https://pubs.acs.org/10.1021/acssynbio.2c00477

### Author Contributions

R.L.-I. and D.M. conceived the project and wrote the manuscript. R.L.-I. constructed the plasmids. R.L.-I. and P.D.-M. performed the experiments.

### Notes

The authors declare no competing financial interest.

## ACKNOWLEDGMENTS

We would like to thank E. Krin and M. Gugger for providing chromosome DNA for *V. cholerae* and *V. fischeri*, and *N. punctiforme* cells, respectively. This work was supported by the Institut Pasteur (to D.M.'s unit), the Centre National de la Recherche Scientifique (Grant No. CNRS-UMR 3525) (to D.M.), PLASWIRES 612146/FP7-FET-Proactive (to D.M.'s unit, and R.L.-I.), the French Government's Investissement d'Avenir program, Laboratoire d'Excellence "Integrative Biology of Emerging Infectious Diseases" (Grant No. ANR-10-LABX-62-IBEID to D.M.'s unit), the Fondation pour la Recherche Médicale (Grant No. EQU202103012569 to P.D.-M. to D.M.), and Grant PID2019-104784RJ-100 MCIN/AEI/10.13039/501100011033 Spain and Grant BFU2017-88202-P MCIN/AEI/10.13039/501100011033 Spain, cofinanced by ERDF A Way of Making Europe to R.L.-I.

## REFERENCES

(1) Anderson, J. C.; Clarke, E. J.; Arkin, A. P.; Voigt, C. A. Environmentally Controlled Invasion of Cancer Cells by Engineered Bacteria. *J. Mol. Biol.* **2006**, *355* (4), 619–627.

(2) Atsumi, S.; Hanai, T.; Liao, J. C. Non-Fermentative Pathways for Synthesis of Branched-Chain Higher Alcohols as Biofuels. *Nature* **2008**, *451* (7174), 86–89.

(3) Martin, V. J. J.; Pitera, D. J.; Withers, S. T.; Newman, J. D.; Keasling, J. D. Engineering a Mevalonate Pathway in *Escherichia coli* for Production of Terpenoids. *Nat. Biotechnol.* **2003**, *21* (7), 796–802.

(4) Paddon, C. J.; Westfall, P. J.; Pitera, D. J.; Benjamin, K.; Fisher, K.; McPhee, D.; Leavell, M. D.; Tai, a; Main, a; Eng, D.; Polichuk, D. R.; Teoh, K. H.; Reed, D. W.; Treynor, T.; Lenihan, J.; Fleck, M.; Bajad, S.; Dang, G.; Dengrove, D.; Diola, D.; Dorin, G.; Ellens, K. W.; Fickes, S.; Galazzo, J.; Gaucher, S. P.; Geistlinger, T.; Henry, R.; Hepp, M.; Horning, T.; Iqbal, T.; Jiang, H.; Kizer, L.; Lieu, B.; Melis, D.; Moss, N.; Regentin, R.; Secrest, S.; Tsuruta, H.; Vazquez, R.; Westblade, L. F.; Xu, L.; Yu, M.; Zhang, Y.; Zhao, L.; Lievense, J.; Covello, P. S.; Keasling, J. D.; Reiling, K. K.; Renninger, N. S.; Newman, J. D. High-Level Semi-Synthetic Production of the Potent Antimalarial Artemisinin. *Nature* **2013**, *496* (7446), 528–532.

(5) Cookson, N. a; Mather, W. H.; Danino, T.; Mondragón-Palomino, O.; Williams, R. J.; Tsimring, L. S.; Hasty, J. Queueing up for Enzymatic Processing: Correlated Signaling through Coupled Degradation. *Mol. Syst. Biol.* **2011**, *7* (1), 561.
(6) Unterholzner, S. J.; Poppenberger, B.; Rozhon, W. Toxin-Antitoxin Systems: Biology, Identification, and Application. *Mob. Genet.* **Elements 2013**, *3* (5), No. e26219.

(7) Bernard, P.; Couturier, M. Cell Killing by the F Plasmid CcdB Protein Involves Poisoning of DNA-Topoisomerase II Complexes. *J. Mol. Biol.* **1992**, *226* (3), 735–745.

(8) Bukowski, M.; Rojowska, A.; Wladyka, B. Prokaryotic Toxin-Antitoxin Systems—the Role in Bacterial Physiology and Application in Molecular Biology. *Acta Biochim. Pol.* **2011**, *58* (1), 1–9.

(9) Park, S. J.; Son, W. S.; Lee, B. J. Structural Overview of Toxin-Antitoxin Systems in Infectious Bacteria: A Target for Developing Antimicrobial Agents. *Biochimica et Biophysica Acta - Proteins and Proteomics* **2013**, *1834*, 1155–1167.

(10) Stieber, D.; Gabant, P.; Szpirer, C. Y. The Art of Selective Killing: Plasmid Toxin/Antitoxin Systems and Their Technological Applications. *Biotechniques* **2008**, *45* (3), 344–346.

(11) Kahan, R.; Worm, D. J.; De Castro, G. V.; Ng, S.; Barnard, A. Modulators of Protein-Protein Interactions as Antimicrobial Agents. *RSC Chem. Biol.* **2021**, *2* (2), 387–409.

(12) López-Igual, R.; Bernal-Bayard, J.; Rodríguez-Patón, A.; Ghigo, J. M.; Mazel, D. Engineered Toxin-Intein Antimicrobials Can. Selectively Target and Kill Antibiotic-Resistant Bacteria in Mixed Populations. *Nat. Biotechnol.* **2019**, *37*, 755.

(13) Nanda, A.; Nasker, S. S.; Mehra, A.; Panda, S.; Nayak, S. Inteins in Science: Evolution to Application. *Microorganisms* **2020**, *8* (12), 2004.

(14) Pinto, F.; Thornton, E. L.; Wang, B. An Expanded Library of Orthogonal Split Inteins Enables Modular Multi-Peptide Assemblies. *Nat. Commun.* **2020**, DOI: 10.1038/s41467-020-15272-2.

(15) Aranko, A. S.; Wlodawer, A.; Iwai, H. Nature's Recipe for Splitting Inteins. *Protein Engineering, Design and Selection* **2014**, *27*, 263.

(16) Lin, Y.; Li, M.; Song, H.; Xu, L.; Meng, Q.; Liu, X. Q. Protein Trans-Splicing of Multiple Atypical Split Inteins Engineered from Natural Inteins. *PLoS One* **2013**, *8*, e59516.

(17) Iwai, H.; Züger, S.; Jin, J.; Tam, P. H. Highly Efficient Protein Trans-Splicing by a Naturally Split DnaE Intein from *Nostoc punctiforme*. *FEBS Lett.* **2006**, *580*, 1853.

(18) Dassa, B.; Amitai, G.; Caspi, J.; Schueler-Furman, O.; Pietrokovski, S. Trans Protein Splicing of Cyanobacterial Split Inteins in Endogenous and Exogenous Combinations. *Biochemistry* **2007**, *46*, 322.

(19) Sorci, M.; Dassa, B.; Liu, H.; Anand, G.; Dutta, A. K.; Pietrokovski, S.; Belfort, M.; Belfort, G. Oriented Covalent Immobilization of Antibodies for Measurement of Intermolecular Binding Forces between Zipper-like Contact Surfaces of Split Inteins. *Anal. Chem.* **2013**, *85*, 6080.

(20) Shah, N. H.; Dann, G. P.; Vila-Perelló, M.; Liu, Z.; Muir, T. W. Ultrafast Protein Splicing Is Common among Cyanobacterial Split Inteins: Implications for Protein Engineering. *J. Am. Chem. Soc.* **2012**, *134* (28), 11338–11341.

(21) Iqbal, N.; Guérout, A. M.; Krin, E.; Le Roux, F.; Mazel, D. Comprehensive Functional Analysis of the 18 *Vibrio cholerae* N16961 Toxin-Antitoxin Systems Substantiates Their Role in Stabilizing the Superintegron. *J. Bacteriol.* **2015**, *197* (13), 2150–2159.

(22) Gibson, D. G.; Young, L.; Chuang, R.-Y.; Venter, J. C.; Hutchison, C. A.; Smith, H. O. Enzymatic Assembly of DNA Molecules up to Several Hundred Kilobases. *Nat. Methods* **2009**, *6* (5), 343–345.

(23) Guzman, L. M.; Belin, D.; Carson, M. J.; Beckwith, J. Tight Regulation, Modulation, and High-Level Expression by Vectors Containing the Arabinose P(BAD) Promoter. *J. Bacteriol.* **1995**, *177* (14), 4121–4130.

(24) Bartolome, B.; Jubete, Y.; Martinez, E.; de la Cruz, F. Construction and Properties of a Family of PACYC184-Derived Cloning Vectors Compatible with PBR322 and Its Derivatives. *Gene* **1991**, *102* (1), 75–78.

(25) Pant, A.; Anbumani, D; Bag, S.; Mehta, O.; Kumar, P.; Saxena, S.; Nair, G. B.; Das, B. Effect of LexA on Chromosomal Integration of CTXφ in *Vibrio cholerae*. *J Bacteriol.* **2016**, *198*, 268–275.